 |
|
Precision medicine and nucleotide-based therapeutics to treat steatotic liver disease
Andrea Caddeo, Stefano Romeo
Clin Mol Hepatol. 2025;31(Suppl):S76-S93. Published online 2024 Aug 5 DOI: https://doi.org/10.3350/cmh.2024.0438
|
|
Citations to this article as recorded by
 Rodent model of metabolic dysfunction‐associated fatty liver disease: a systematic review
Xiao‐Shan Cui, Hong‐Zheng Li, Liang Li, Cheng‐Zhi Xie, Jia‐Ming Gao, Yuan‐Yuan Chen, Hui‐Yu Zhang, Wei Hao, Jian‐Hua Fu, Hao Guo
Journal of Gastroenterology and Hepatology.2025; 40(1): 48. CrossRef Role of PNPLA3 in Hepatic Stellate Cells and Hepatic Cellular Crosstalk
Maria Castanho Martins, Emmanuel Dauda Dixon, Giulia Lupo, Thierry Claudel, Michael Trauner, Krista Rombouts
Liver International.2025;[Epub] CrossRef Novel Therapies for Nonalcoholic Steatohepatitis (NASH) and Cardiovascular Risk Reduction
Tarun Biswas, Angelica Lehker, Debabrata Mukherjee
Cardiovascular & Hematological Disorders-Drug Targets.2025; 24(4): 211. CrossRef Liver-specific inactivation of Cideb improves metabolic profiles and ameliorates steatohepatitis and fibrosis in animal models for MASH
Jianhua Zhang, Xujie Liu, Xian Jin, Xudong Mao, Xueli Xu, Xing Zhang, Ke Shang, Yuan Xu, Yanhuan Zhang, Guofeng Meng, Ming Yue, Guoqing Cai, Song Yang, Jinyu Huang, Jianwu Fang, Ling Pan, Lei Jiang, Stella Shi, Jianyong Shou
Pharmacological Research.2025; 214: 107664. CrossRef Circadian control of hepatic ischemia/reperfusion injury via HSD17B13-mediated autophagy in hepatocytes
Hui Wang, Meina Guo, Baoyin Ren, Haibo Zhang, Jiayang Zhang, Rongfang Qiao, Lei Qian, Jingwen Zhu, Shuying Zhang, Wen Su, Xiaoyan Zhang, Guangrui Yang, Youfei Guan, Lihong Chen
Journal of Hepatology.2025;[Epub] CrossRef Reversed role of CD36 deficiency in high-fat diet or methionine/choline-deficient diet-induced hepatic steatosis and steatohepatitis
Wenya Zhu, Jialing Ma, Tingting Zhang, Mengmeng Zhu, Yajun Duan, Xiaoxiao Yang, Yuanli Chen
Frontiers in Pharmacology.2025;[Epub] CrossRef Hepatocyte nuclear factor 4-Alpha: a key regulator in liver carcinogenesis
Hayam Hamdy, Chang Shen, Jiashun Xu, Die Fan, Yiwen Zhang, Hui Li, Yonglong Wei, Jianwei Sun
Cellular Oncology.2025;[Epub] CrossRef Targeting CIDEB alleviates liver steatosis and fibrosis in mouse MASH models
Yingying Lin, Fushun Fan, Zhenxian Mo, Ziyang Huang, Minhua Zhou, Yaru Ma, Chuiwen Qian, Yifei Wang, Changgeng Qian, Xinjian Liu
Molecular Therapy Nucleic Acids.2025; 36(2): 102567. CrossRef Polygenic Risk Score for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Narrative Review
Tatsuo Kanda, Reina Sasaki-Tanaka, Hiroyuki Abe, Naruhiro Kimura, Tomoaki Yoshida, Kazunao Hayashi, Akira Sakamaki, Takeshi Yokoo, Hiroteru Kamimura, Atsunori Tsuchiya, Kenya Kamimura, Shuji Terai
International Journal of Molecular Sciences.2025; 26(11): 5164. CrossRef Gelsolin's Protective Role in MASH through F‐Actin Regulation and P53 Degradation
Yiwei Lu, Tong Ji, Zhichao Ye, Jianing Yan, Chao Wang, Jiachen Chen, Ziyang Jin, Yongji Zhu, Xiujun Cai, Yifan Wang
Advanced Science.2025;[Epub] CrossRef Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances
Liangtao Zhao, Haolan Tang, Zhangjun Cheng
Pharmaceuticals.2024; 17(12): 1724. CrossRef
|